tradmap

MACD Bullish Stocks — Valuation View · Medicinal Chemicals & Botanical Products

12 stocks match the MACD Bullish Stocks screen. Stocks whose MACD line is above its signal line — a bullish momentum state, largest first. Valuation columns. Filtered to Medicinal Chemicals & Botanical Products. Data as of close · Checked

Filters2
1–12 of 12
DFTXDefinium Therapeutics, Inc.$4.5B-12.69—4.896.85—33.41+2.93%110K
TRLVTrulieve Cannabis Corp.$2.2B-4.661.952.906.82—11.52+3.78%60K
CRONCronos Group$1.2B17.826.961.172.67—3.38+1.04%73K
SNDLSNDL Inc.$354M—————1.34+5.08%95K
CGCCanopy Growth$301M-1.801.430.611.25—0.71+4.42%90K
ACBAurora Cannabis$290M—————5.16+22.16%430K
USNAUSANA HEALTH SCIENCES INC$275M-12.390.300.521.63—14.86+1.16%28K
GLASGlass House Brands Inc.$190M-6.411.042.578.14—2.32-0.85%35K
NAGENiagen Bioscience, Inc.$187M18.251.532.252.69—2.36-1.67%43K
MDWDMediWound Ltd.$173M—————13.44-0.52%4K
BTMDbiote Corp.$32M5.530.18—2.90—1.13-0.44%2K
NAIINATURAL ALTERNATIVES INTERNATIONAL INC$6M-0.300.040.120.84—1.07-3.60%99

Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.